Vanta Bioscience Stock Screener | Share Price & Fundamental Analysis
VANTABIO
Healthcare Technology
Track Vanta Bioscience share price live with TickJournal's free stock screener.
Browse VANTABIO financial statements to support your investment research.
Record your trades in TickJournal's free trading journal and track your portfolio performance.
Vanta Bioscience Market Cap
₹12.95 Cr.
VANTABIO P/E Ratio (TTM)
-
Vanta Bioscience P/B Ratio
0.75
EPS (TTM)
₹-7.56
Dividend Yield
-
Debt to Equity
5.11
VANTABIO 52 Week High
-
Vanta Bioscience 52 Week Low
-
Operating Margin
-206.00%
Profit Margin
-100.00%
VANTABIO Revenue (TTM)
₹1.00
EBITDA
₹-1.00
Net Income
₹-1.00
Total Assets
₹86.00
Total Equity
₹4.00
Vanta Bioscience Share Price History - Stock Screener Chart
Screen VANTABIO historical share price movements with interactive charts. Analyze price trends and patterns.
Vanta Bioscience Company Profile - Fundamental Screener
Screen Vanta Bioscience company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for VANTABIO shares.
Sector
Healthcare
Industry
Healthcare Technology
Sub-Sector
Healthcare Technology
Segment
E
ISIN
INE695X01011
Vanta Bioscience Balance Sheet Screener
Screen VANTABIO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Total Assets | 86 | 85 | 85 | 81 | 70 | 49 | 39 |
| Current Assets | 15 | 17 | 15 | 15 | 20 | 20 | 17 |
| Fixed Assets | 56 | 54 | 57 | 36 | 29 | 21 | 18 |
| Liabilities | |||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 56 | 50 | 48 | 34 | 29 | 14 | 13 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||||
| Total Equity | 4 | 13 | 19 | 29 | 26 | 25 | 23 |
| Share Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves & Surplus | 4 | 9 | 11 | 18 | 18 | 17 | 16 |
Vanta Bioscience Income Statement Screener - Profit & Revenue Analysis
Screen Vanta Bioscience income statement and profit fundamentals.
Analyze VANTABIO quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Vanta Bioscience share price evaluation.
| Item | 2023-Mar | 2022-Dec | 2022-Mar | 2021-Dec |
|---|---|---|---|---|
| Revenue | 1 | 3 | 5 | 0 |
| Expenses | 2 | 3 | 2 | 0 |
| EBITDA | -1 | -1 | 2 | 0 |
| Operating Profit % | -206.00% | -20.00% | 46.00% | 0.00% |
| Depreciation | 0 | 1 | 1 | 0 |
| Interest | 1 | 3 | 1 | 0 |
| Profit Before Tax | -2 | -4 | 1 | 0 |
| Tax | 0 | -2 | 0 | 0 |
| Net Profit | -1 | -3 | 0 | 0 |
| EPS | 0.00 | -4.06 | 0.11 | 0.00 |
Vanta Bioscience Cash Flow Screener - Liquidity Fundamentals
Screen VANTABIO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|
| Operating Activities | -2 | 3 | -1 | 5 | 7 | 2 | -1 |
| Investing Activities | -7 | -3 | -6 | -17 | -22 | -8 | -6 |
| Financing Activities | 9 | 1 | 6 | 10 | 18 | 2 | 10 |
| Net Cash Flow | 0 | 0 | 0 | -2 | 3 | -3 | 3 |
Vanta Bioscience Shareholding Pattern Screener
See Vanta Bioscience shareholding pattern with promoter, FII, and DII holdings.
Check Vanta Bioscience promoter holding and ownership changes for VANTABIO on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Sept | 2023-Mar | 2023-Sept | 2022-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 69.36% | 72.81% | 72.81% | 69.36% | 69.36% | 69.36% | 69.36% | 69.00% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 26.35% | 23.39% | 23.66% | 25.97% | 26.55% | 26.77% | 26.77% | 26.35% |
| Other Holding | 4.29% | 3.81% | 3.53% | 4.67% | 4.09% | 3.87% | 3.87% | 4.65% |
| Shareholder Count | 408 | 408 | 419 | 418 | 424 | 394 | 388 | 409 |
Vanta Bioscience Share Dividend Screener - Share Yield Analysis
Check Vanta Bioscience dividend history with payout and yield data.
View Vanta Bioscience dividend details including ex-dates and amounts for VANTABIO stock.
Vanta Bioscience Stock Index Membership
See which indices include Vanta Bioscience stock.
Check VANTABIO index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Vanta Bioscience Market Events Screener - Corporate Actions
Get Vanta Bioscience corporate actions including splits, bonuses, and buybacks.
Check Vanta Bioscience stock events that may affect VANTABIO share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 9.19% | ||
| Annual General Meeting | NA | 4.98% | ||
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -5.00% |
| 2025-08-01 | 2025-08-01 | Quarterly Result Announcement | NA | 18.62% |
| 2025-01-04 | 2025-01-04 | Extraordinary General Meeting | NA | -2.97% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -9.75% |
Vanta Bioscience Competitors Screener - Peer Comparison
Screen VANTABIO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Syngene International | 16,305 | 45.03 | 3,714 | 3.77% | 496 | 46.50 |
| Indegene | 11,806 | 26.92 | 2,947 | 10.53% | 407 | 59.88 |
| Suven Life Sciences | 4,535 | -17.11 | 18 | -46.34% | -161 | 79.86 |
| Vimta Labs | 2,069 | 31.88 | 322 | 0.22% | 41 | 59.01 |
| Take Solutions | 673 | 405.36 | 10 | 126.67% | 1 | 67.35 |
| Bilcare | 146 | -3.47 | 807 | 4.78% | -56 | 59.91 |
| Jeevan Scientific Technology | 137 | -63.78 | 48 | 17.87% | 0 | 59.30 |
| Adeshwar Meditex | 22 | 33.09 | 84 | 5.00% | 2 | 23.03 |
| Vanta Bioscience | 13 | -0.81 | 2 | -78.57% | -13 | 51.07 |
Vanta Bioscience Company Announcements - News Screener
Screen VANTABIO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-04-12 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-24 | Closure of Trading Window | - |
| 2026-03-11 | Clarification On Movement In Price | - |
| 2026-02-25 | Clarification sought from Vanta Bioscience Ltd | - |
| 2026-01-30 | Board Meeting Outcome for Outcome Of The Board Meeting - Appointment Of Company Secretary And Compliance Officer | - |
| 2025-11-14 | Financial Results For The Half Year Ended September 30 2025 | - |
| 2025-11-14 | Board Meeting Outcome for Outcome Of The Board Meeting Held On November 14 2025 | - |
| 2025-11-08 | Board Meeting Intimation for Board Meeting To Be Held On 14.11.2025 | - |
| 2025-11-01 | Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer | - |
| 2025-11-01 | Reg. 34 (1) Annual Report. | - |
| 2025-10-03 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2025-09-30 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2025-09-30 | Closure of Trading Window | - |
| 2025-09-06 | Board Meeting Outcome for Outcome Of Board Meeting Held On 06.09.2025 | - |
| 2025-08-01 | Financials For The Half Year And Year Ended 31.03.2025 | - |
| 2025-08-01 | Board Meeting Outcome for Outcome Of The Board Meeting Held On 01.08.2025 | - |
| 2025-07-29 | Board Meeting Intimation for Postponement Of Board Meeting To August 01 2025 | - |
| 2025-07-26 | Board Meeting Intimation for Postponement Of Board Meeting To July 29 2025 | - |
| 2025-07-19 | Board Meeting Intimation for Postponement Of Board Meeting Scheduled On July 19 2025 And Will Now Be Held On Thursday July 24 2025 | - |
| 2025-07-16 | Board Meeting Intimation for Board Meeting To Be Held On July 19 2025 | - |